MUSC Health logo

UNIV - Open Rank - Cytogenetics & Genomics (Cytogenomics) Laboratory Director - Department of Pathology and Laboratory Medicine

MUSC Health

Charleston, SCOnsitePosted 2 days ago
Full TimeSenior LevelResearch & ScientistHealthcare Provider
Original posting ↗

Summary

The Department of Pathology and Laboratory Medicine at the Medical University of South Carolina (MUSC) invites applications for an academically oriented Cytogenetics & Genomics (Cytogenomics) Laboratory Director. The successful candidate will join faculty directors who share medical and scientific oversight of the Cytogenetics, Genomics, and Molecular Pathology laboratories. The laboratories provide constitutional and somatic testing using chromosome analysis, fluorescence in situ hybridization (FISH), SNP microarray, and next-generation sequencing (NGS), with continued expansion into other precision pathology initiatives, including pharmacogenetics and pharmacogenomics. This recruitment places particular emphasis on expertise in cancer testing and interpretation for both solid tumors and hematologic malignancies.

Job description

Job Description Summary

The Department of Pathology and Laboratory Medicine at the Medical University of South Carolina (MUSC) invites applications for an academically oriented Cytogenetics & Genomics (Cytogenomics) Laboratory Director. The successful candidate will join faculty directors who share medical and scientific oversight of the Cytogenetics, Genomics, and Molecular Pathology laboratories. The laboratories provide constitutional and somatic testing using chromosome analysis, fluorescence in situ hybridization (FISH), SNP microarray, and next-generation sequencing (NGS), with continued expansion into other precision pathology initiatives, including pharmacogenetics and pharmacogenomics. This recruitment places particular emphasis on expertise in cancer testing and interpretation for both solid tumors and hematologic malignancies.

Responsibilities

  • Interpret and report constitutional and somatic genomic test results, including chromosome analysis, FISH, SNP microarray, and NGS.
  • Provide expert interpretation of genomic alterations in solid tumors and hematologic malignancies, integrating cytogenetic, FISH, array, and sequence findings when appropriate.
  • Develop and maintain competence across the Cytogenetics, Genomics, and Molecular Pathology testing portfolio, including constitutional genetics and other precision pathology applications such as pharmacogenetics and pharmacogenomics.
  • Assume lead responsibility for one or more areas of significant expertise, training, or experience, while participating in shared directorship and cross-coverage responsibilities.
  • Participate in the development, validation, implementation, performance monitoring, and continuous improvement of new and existing clinical tests.
  • Share responsibility for the laboratory quality management system, regulatory compliance, proficiency testing, accreditation activities, personnel competency oversight, test utilization, and strategic program development.
  • Serve as a clinical consultant regarding test selection, testing strategies, and interpretation of complex genomic findings.
  • Collaborate with laboratory professionals and multidisciplinary teams in Pathology, Hematology, Oncology, Genetics, Pharmacy, and other clinical and research programs to advance precision diagnostics and personalized care.
  • Participate in clinical, translational, or collaborative research, including opportunities through MUSC Hollings Cancer Center.
  • Teach and mentor medical students, pathology residents, fellows, graduate students, and laboratory personnel.
  • Contribute to the academic, scholarly, and service missions of the Department of Pathology and Laboratory Medicine.

Required Qualifications

PhD Candidates: PhD or equivalent doctoral degree in genetics, genomics, human genetics, or a related biological science. Board certification or active board eligibility by the American Board of Medical Genetics and Genomics (ABMGG) in Laboratory Genetics and Genomics (LGG).

MD/DO Candidates: MD, DO, or equivalent medical degree. Board certified or actively board eligible by the American Board of Pathology (ABPath) in Anatomic and Clinical Pathology (AP/CP).

All Candidates: Demonstrated expertise in constitutional and somatic genomic testing, including cancer genomics and genomic testing for solid tumors and hematologic malignancies. Demonstrated ability to interpret clinical genomic testing, with particular strength in cancer testing for solid tumors and/or hematologic malignancies. Experience with one or more of the laboratory's principal testing modalities: chromosome analysis, FISH, microarray, and NGS. Experience with clinical test development, validation or verification, implementation, and ongoing performance assessment in a CLIA-certified, CAP-accredited laboratory. Qualifications to fulfill applicable CLIA requirements for director oversight of high-complexity testing. Eligibility for applicable South Carolina professional licensure. Commitment to collaborative patient care, education, scholarship, and development of competence across the full laboratory testing portfolio.

Preferred Qualifications

  • Established expertise in integrated cancer cytogenomics or molecular oncology, including solid tumor and hematologic malignancy testing.
  • Experience integrating chromosome, FISH, microarray, and NGS findings for diagnostic, prognostic, predictive, and therapeutic interpretation.
  • Experience in pharmacogenetics or pharmacogenomics, constitutional genomics, laboratory informatics, quality management, or development of other precision pathology services.
  • A record of teaching, collaborative research, scholarly activity, or clinical program development.

Requirements

  • PhD or equivalent doctoral degree in genetics, genomics, human genetics, or a related biological science (PhD candidates)
  • Board certification or active board eligibility by ABMGG in Laboratory Genetics and Genomics (LGG) (PhD candidates)
  • MD, DO, or equivalent medical degree (MD/DO candidates)
  • Board certified or actively board eligible by ABPath in Anatomic and Clinical Pathology (AP/CP) (MD/DO candidates)
  • Demonstrated expertise in constitutional and somatic genomic testing, including cancer genomics and genomic testing for solid tumors and hematologic malignancies
  • Demonstrated ability to interpret clinical genomic testing, with particular strength in cancer testing for solid tumors and/or hematologic malignancies
  • Experience with one or more of the laboratory's principal testing modalities: chromosome analysis, FISH, microarray, and NGS
  • Experience with clinical test development, validation or verification, implementation, and ongoing performance assessment in a CLIA-certified, CAP-accredited laboratory
  • Qualifications to fulfill applicable CLIA requirements for director oversight of high-complexity testing
  • Eligibility for applicable South Carolina professional licensure
  • Commitment to collaborative patient care, education, scholarship, and development of competence across the full laboratory testing portfolio

Benefits

  • Academic environment
  • Research opportunities
  • Clinical collaboration
  • Teaching opportunities

Company overview

MUSC Health is the healthcare system of the Medical University of South Carolina, serving as the state's premier academic medical center and comprehensive healthcare provider. Founded in 1824 and headquartered in Charleston, South Carolina, MUSC Health operates 14 hospitals with approximately 2,500 beds and has five additional hospital locations in development. The organization provides patient care through more than 350 telehealth sites and nearly 750 care locations across all regions of South Carolina, serving 46 counties throughout the state. For 11 consecutive years, U.S. News & World Report has ranked MUSC Health as the number one hospital in South Carolina, reflecting its commitment to clinical excellence and patient safety. As an integrated academic health system, MUSC Health combines clinical care with medical education and research, training more than 900 residents and fellows annually while conducting groundbreaking research with $360 million in research funding and 1,268 active clinical trials. The organization employs over 10,000 team members and handles approximately 3.21 million patient encounters each year, delivering specialized services in cancer care, cardiac services, digestive health, women's health, and numerous other medical specialties through its Hollings Cancer Center and other specialized institutes.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.